Evaluation of mass drug administration for schistosomiasis and soil-transmitted helminths in school-aged children in Bankass, Mali
| Autor: | Adama Berthe, Abdoul Fatao Diabate, Kueshivi Midodji Atsou, Abdallah A. Diallo, Salif Seriba Doumbia, Fatoumata dite Nènè Konipo, Seydou Doumbia, Moussa Brema Sangare, Yaya Ibrahim Coulibaly, Yacouba Sanogo, Modibo Keita, Siaka Y. Coulibaly, Housseini Dolo, Michel Emmanuel Coulibaly, Lamine Diarra, Lamine Soumaoro |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2021 |
| Předmět: |
Microbiology (medical)
Population Psychological intervention Helminthiasis Schistosomiasis Infectious and parasitic diseases RC109-216 Mali Health informatics Albendazole Soil Environmental health Helminths medicine Prevalence Animals Humans Mass drug administration education Child Evaluation Anthelmintics education.field_of_study Schools business.industry Soil-transmitted helminths Reproducibility of Results General Medicine medicine.disease Praziquantel Infectious Diseases Cross-Sectional Studies Community health Bankass and Mali School-aged children business medicine.drug |
| Zdroj: | International Journal of Infectious Diseases, Vol 112, Iss, Pp 196-201 (2021) |
| ISSN: | 1201-9712 |
| Popis: | Background In 2004, Mali implemented mass drug administration (MDA) aimed at controlling schistosomiasis and soil-transmitted helminths. Despite several rounds of MDA, the health district of Bankass reported low coverage (64.8%) for praziquantel and albendazole in 2017, meaning that this district was still facing challenges in accomplishing the targeted 75% coverage. This study aimed to explore the barriers and gaps that hindered MDA implementation in Bankass. Methods A cross-sectional study was performed. Questionnaires were administrated to all school-aged children in randomly selected villages. Technical directors of community health centers and community drug distributors in the selected villages were included in the interviews. Results A total of 2128 children and 52 health workers were interviewed. Coverage rates were 93.51% (1990/2128) for praziquantel and 95.25% (2027/2128) for albendazole. Among the untreated children, 31.63% (31/98) reported being unaware of the campaign and 26.53% (26/98) were unable to reach the distribution points. Most of the health workers suggested increasing incentives. Conclusion The data showed satisfactory coverage >90%, in contrast with lower rates initially reported by the district health information system. These results raise concerns about the reliability of programmatic data and highlight the importance of population-based surveys for the evaluation of control interventions. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|